Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.
Description
Limbic is an innovative clinical-AI platform specifically designed for behavioral health professionals that improves patient accessibility, speeds up assessments, and aids in therapy with reliable AI-driven tools. It integrates seamlessly into referral systems, offering Limbic Access, an interactive intake and screening agent that carries out evaluations, forecasts diagnoses, assesses risk levels, and produces comprehensive clinical reports for healthcare providers. In addition, Limbic provides Limbic Care, an AI companion for patients that offers structured CBT interventions, conversational check-ins, and ongoing support tailored to the individual's therapeutic plan. Central to this platform is the Limbic Layer, a proprietary clinical engine that operates between users and an extensive language model, ensuring safety, clinical accuracy, adherence to regulations, and uniformity. The platform's efficacy is underscored by its impressive diagnostic precision and is supported by peer-reviewed research and recognized regulatory endorsements, including its classification as a Class IIa medical device. Furthermore, Limbic's commitment to enhancing mental health treatment reflects a broader trend in healthcare towards integrating technology for improved patient outcomes.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Altis Labs
Founded
2019
Country
Canada
Website
www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d
Vendor Details
Company Name
Limbic
Founded
2018
Country
United Kingdom
Website
www.limbic.ai/
Product Features
Product Features
Mental Health
Appointment Reminders
Appointment Scheduling
Assessment & Treatment Plans
Billing & Invoicing
Claims Management
E-Prescribing
EDI
EMR / EHR
HIPAA Compliant
Inpatient / Residential
Multi-Provider Practice
Patient Portal
Personnel Management
Progress Notes
Single Provider Practice